Loading...
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
Combination therapies that display cancer-killing activities through either coexistent targeting of several cellular factors or more efficient suppression of a specific pathway are generally used in cancer treatment. Sildenafil, a specific phosphodiesterase type 5 (PDE5) inhibitor, has been suggeste...
Saved in:
| Published in: | Front Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Frontiers Media S.A.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7427565/ https://ncbi.nlm.nih.gov/pubmed/32850387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|